Categories: BrainNews

Soterix Medical Announces FDA 510(k) Clearance of MEGA-IOM Intraoperative Neuromonitoring System

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

WOODBRIDGE, N.J., July 24, 2024 /PRNewswire/ — Soterix Medical Inc., the global leader in stimulation and synergistic monitoring technologies, announced today it has received a 510(k) clearance from the U.S. Food & Drug Administration for its Intraoperative Neurophysiologic Monitoring (IOM) system, MEGA-IOM. The system provides unmatched integrated control of central and peripheral nervous systems to reduce postoperative risk and improve surgical outcomes. ­It includes preset modalities such as motor evoked potentials (MEP) to evaluate the integrity of motor pathways, somatosensory evoked potentials (SSEP) to evaluate the integrity of sensory pathways and detect brain and spinal cord ischemia, EEG to record and analyze brain activity (functional state of the brain), and direct stimulation to control the functional integrity of peripheral nerves.

MEGA-IOM provides unmatched integrated control of central and peripheral nervous systems to reduce postoperative risk.

“This FDA authorization represents a significant milestone for our organization as we can now offer the MEGA-IOM system to surgical teams across the U.S.,” said Ms. Danielle Dadona, VP of Regulatory Affairs of Soterix Medical. “This U.S. manufactured system pairs with an intuitive, rich, software interface with exceptional usability.”

Mr. Kamran Nazim, Chief Product Officer of Soterix Medical commented “MEGA-IOM is a cutting-edge modular platform solution that combines years of knowledge and experience obtained in clinical and research environments. Due to flexible channel configuration and size options (cart-based or portable), the system can meet the most exacting needs of both surgeons and advanced neuromonitoring specialists.”

Surgeons, neurophysiologists, neurologists and intraoperative monitoring service companies in the United States interested in incorporating the MEGA-IOM system are eligible for Soterix Medical’s Partnership program which includes support on the entire system, hands-on training and staff certification. Interested parties should contact Soterix Medical (at contact@soterixmedical.com) for additional information.

Media Contact: Chaya Edelman
Tel: +1-888-990-8327
Email: contact@soterixmedical.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/soterix-medical-announces-fda-510k-clearance-of-mega-iom-intraoperative-neuromonitoring-system-302204284.html

SOURCE Soterix Medical, Inc.

Staff

Recent Posts

Health in Tech Expands Access to Virtual Care Through Collaboration with DialCare

STUART, Fla., March 25, 2025 /PRNewswire/ -- Health In Tech (Nasdaq: HIT), an Insurtech platform…

5 hours ago

Concord Orthopaedic Notifies Individuals of Security Incident

CONCORD, N.H., March 25, 2025 /PRNewswire/ -- Concord Orthopaedic ("COPA") is an orthopedic clinic located…

5 hours ago

Mitolyn Brand Takes Legal Action Against Third-Party Sellers for Misinformation

HAMPTON, Va., March 25, 2025 /PRNewswire/ -- Bioventra, the parent company and official manufacturer of Mitolyn,…

5 hours ago

THE MOM’S CHOICE AWARDS NAMES AI-POWERED PREGNANCY & BABY WELLNESS WEARABLE ‘ELORA’ AMONG THE BEST IN FAMILY-FRIENDLY PRODUCTS

DOVER, Del., March 25, 2025 /PRNewswire/ -- The Mom's Choice Awards® has named Elora*, from leading…

5 hours ago

Paving the Way for Early Esophageal Cancer Detection:

New Sampling Technique Further Optimizes WATS3D Test Quality SUFFERN, N.Y., March 25, 2025 /PRNewswire/ -- CDx…

5 hours ago

Appeals Court Upholds Bankruptcy Court’s Ruling on Hazel Hawkins Memorial Hospital’s Chapter 9 Eligibility

HOLLISTER, Calif., March 25, 2025 /PRNewswire/ -- Friday, the Appeals Court upheld the Bankruptcy Court's…

5 hours ago